Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
The Christie NHS Foundation Trust
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dragonfly Therapeutics
National Institutes of Health Clinical Center (CC)
AstraZeneca
Dana-Farber Cancer Institute
Mayo Clinic
National Institutes of Health Clinical Center (CC)
Ohio State University
Hoffmann-La Roche
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Psyence Australia Pty Ltd
Neonc Technologies, Inc.
ViroMissile, Inc.
Bristol-Myers Squibb
Dana-Farber Cancer Institute
Kaiser Permanente
Children's Oncology Group
AstraZeneca
Pfizer
Washington University School of Medicine
University of Florida
Tizona Therapeutics, Inc
Aulos Bioscience, Inc.
Essen Biotech
Essen Biotech
National Institutes of Health Clinical Center (CC)
Genentech, Inc.
Azienda Ospedaliero-Universitaria di Parma
Shanghai Henlius Biotech
OHSU Knight Cancer Institute
Wake Forest University Health Sciences
University of Oklahoma
Sapience Therapeutics
MacroGenics
St. Jude Children's Research Hospital
MacroGenics
Adaptimmune
Alliance for Clinical Trials in Oncology
University of California, Davis
City of Hope Medical Center
xCures
Daiichi Sankyo
University of Nebraska
National Institutes of Health Clinical Center (CC)
Second Life Therapeutics
ImmunityBio, Inc.